AAAAAA

   
Results: 1-22 |
Results: 22
SIGNIFICANTLY HIGHER SURVIVAL WITH GEMCITABINE-CISPLATIN VS CISPLATININ ADVANCED NONSMALL CELL LUNG-CANCER (NSCLC) - FINAL RESULTS FROM ANINTERNATIONAL RANDOMIZED PHASE-III STUDY
Authors: SANDLER A DENHAM C VONPAWEL J CORMIER Y GATZEMEIER U MATTSON K MANEGOLD C GREGOR A BLATTER J EINHORN L
Citation: A. Sandler et al., SIGNIFICANTLY HIGHER SURVIVAL WITH GEMCITABINE-CISPLATIN VS CISPLATININ ADVANCED NONSMALL CELL LUNG-CANCER (NSCLC) - FINAL RESULTS FROM ANINTERNATIONAL RANDOMIZED PHASE-III STUDY, Annals of oncology, 9, 1998, pp. 409-409
PHASE-II STUDY OF DOCETAXEL AND CISPLATIN IN A CIRCADIAN TIMING AS FIRST LINE CHEMOTHERAPY (CT) IN ADVANCED NON-SMALL-CELL LUNG-CANCER (NSCLC)
Authors: FADERL B VONPAWEL J WAGNER H KRAUSS C ACHTERRATH W
Citation: B. Faderl et al., PHASE-II STUDY OF DOCETAXEL AND CISPLATIN IN A CIRCADIAN TIMING AS FIRST LINE CHEMOTHERAPY (CT) IN ADVANCED NON-SMALL-CELL LUNG-CANCER (NSCLC), Annals of oncology, 9, 1998, pp. 430-430
EFFECTS OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND DOSE INTENSIFICATION OF V-ICE CHEMOTHERAPY IN SMALL-CELL LUNG-CANCER - A PROSPECTIVE RANDOMIZED STUDY OF 300 PATIENTS
Authors: STEWARD WP VONPAWEL J GATZEMEIER U WOLL P THATCHER N KOSCHEL G CLANCY L VERWEIJ J DEWIT R PFEIFER W FENNELLY J VONEIFF M FRISCH J
Citation: Wp. Steward et al., EFFECTS OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND DOSE INTENSIFICATION OF V-ICE CHEMOTHERAPY IN SMALL-CELL LUNG-CANCER - A PROSPECTIVE RANDOMIZED STUDY OF 300 PATIENTS, Journal of clinical oncology, 16(2), 1998, pp. 642-650
CLINICAL-PHASE-II TRIAL OF TREOSULFAN IN PATIENTS WITH NONRESECTABLE NON-SMALL-CELL LUNG-CANCER
Authors: VONPAWEL J GATZEMEIER U MEHL B EDLER L BAUMGART J DRINGS P
Citation: J. Vonpawel et al., CLINICAL-PHASE-II TRIAL OF TREOSULFAN IN PATIENTS WITH NONRESECTABLE NON-SMALL-CELL LUNG-CANCER, Onkologie, 21(4), 1998, pp. 316-319
PRELIMINARY-RESULTS OF A RANDOMIZED COMPARATIVE PHASE-III TRIAL OF TOPOTECAN VERSUS CAV AS 2ND-LINE THERAPY OF SMALL-CELL LUNG-CANCER
Authors: CLARKE P SCHILLER JH VONPAWEL J KLEISBAUER JP DOBBS T CHRYSSON N DANE G HUDSON I DEWITTE M FIELDS SZ
Citation: P. Clarke et al., PRELIMINARY-RESULTS OF A RANDOMIZED COMPARATIVE PHASE-III TRIAL OF TOPOTECAN VERSUS CAV AS 2ND-LINE THERAPY OF SMALL-CELL LUNG-CANCER, European journal of cancer, 33, 1997, pp. 1032-1032
TOPOTECAN (HYCAMTIN(TM)) IN SMALL-CELL LUNG-CANCER (SCLC) AFTER FAILURE OF FIRST LINE THERAPY - MULTICENTER PHASE-II STUDY
Authors: VONPAWEL J DEPIERRE A HANS K MORO D CLARK P GATZEMEIER U PAILLOT N SCHEITHAUER W CARMICHAEL J SANTORO A ROSS G MARANGOLO M
Citation: J. Vonpawel et al., TOPOTECAN (HYCAMTIN(TM)) IN SMALL-CELL LUNG-CANCER (SCLC) AFTER FAILURE OF FIRST LINE THERAPY - MULTICENTER PHASE-II STUDY, European journal of cancer, 33, 1997, pp. 1038-1038
POOLED ANALYSIS OF TOPOTECAN(T) IN THE 2ND-LINE TREATMENT OF PATIENTS(PTS) WITH SENSITIVE SMALL-CELL LUNG-CANCER (SCLC)
Authors: ECKARDT J DEPIERRE A ARDIZZONI A VONPAWEL J FIELDS S
Citation: J. Eckardt et al., POOLED ANALYSIS OF TOPOTECAN(T) IN THE 2ND-LINE TREATMENT OF PATIENTS(PTS) WITH SENSITIVE SMALL-CELL LUNG-CANCER (SCLC), European journal of cancer, 33, 1997, pp. 1041-1041
GEMCITABINE AND ETOPOSIDE IN CHEMONAIVE PATIENTS WITH EXTENSIVE SMALL-CELL LUNG-CANCER (SCLC) - PRELIMINARY PHASE-II RESULTS
Authors: VONPAWEL J GATZEMEIER U VANSTEENKISTE J WEYNANTS P HANAUSKE A BOSQUEE L MANSOURI K ZNAMENSKY S BLATTER J MANEGOLD C
Citation: J. Vonpawel et al., GEMCITABINE AND ETOPOSIDE IN CHEMONAIVE PATIENTS WITH EXTENSIVE SMALL-CELL LUNG-CANCER (SCLC) - PRELIMINARY PHASE-II RESULTS, European journal of cancer, 33, 1997, pp. 1054-1054
TREATMENT INTENSIFICATION WITH INTERLEUKIN-3 (IL-3) AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) IN PATIENTS WITH SMALL-CELL LUNG-CANCER
Authors: GATZEMEIER U VONPAWEL J TISCHERNEUHAUS R HAUS U FARBER L
Citation: U. Gatzemeier et al., TREATMENT INTENSIFICATION WITH INTERLEUKIN-3 (IL-3) AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) IN PATIENTS WITH SMALL-CELL LUNG-CANCER, European journal of cancer, 33, 1997, pp. 1095-1095
SINGLE-AGENT GEMCITABINE VERSUS CISPLATIN-ETOPOSIDE - EARLY RESULTS OF A RANDOMIZED PHASE-II STUDY IN LOCALLY ADVANCED OR METASTATIC NON-SMALL-CELL LUNG-CANCER
Authors: MANEGOLD C BERGMAN B CHEMAISSANI A DORNOFF W DRINGS P KELLOKUMPULEHTINEN P LIIPPO K MATTSON K VONPAWEL J RICCI S SEDERHOLM C STAHEL RA WAGENIUS G VONWALREE N TENBOKKELHUININK W
Citation: C. Manegold et al., SINGLE-AGENT GEMCITABINE VERSUS CISPLATIN-ETOPOSIDE - EARLY RESULTS OF A RANDOMIZED PHASE-II STUDY IN LOCALLY ADVANCED OR METASTATIC NON-SMALL-CELL LUNG-CANCER, Annals of oncology, 8(6), 1997, pp. 525-529
TOPOTECAN (HYCAMTIN(R)) - POTENT CYTOSTATIC ACTION BY SELECTIVE TOPOISOMERASE-I INHIBITION
Authors: VONPAWEL J
Citation: J. Vonpawel, TOPOTECAN (HYCAMTIN(R)) - POTENT CYTOSTATIC ACTION BY SELECTIVE TOPOISOMERASE-I INHIBITION, Onkologie, 20(5), 1997, pp. 380-386
PACLITAXEL, CARBOPLATIN, AND ORAL ETOPOSIDE - A PHASE-II TRIAL IN LIMITED-STAGE SMALL-CELL LUNG-CANCER
Authors: GATZEMEIER U JAGOS U KAUKEL E KOSCHEL G VONPAWEL J
Citation: U. Gatzemeier et al., PACLITAXEL, CARBOPLATIN, AND ORAL ETOPOSIDE - A PHASE-II TRIAL IN LIMITED-STAGE SMALL-CELL LUNG-CANCER, Seminars in oncology, 24(4), 1997, pp. 149-152
A RANDOMIZED STUDY OF GEMCITABINE MONOTHERAPY VERSUS ETOPOSIDE CISPLATIN IN THE TREATMENT OF LOCALLY ADVANCED OR METASTATIC NONSMALL CELL LUNG-CANCER/
Authors: MANEGOLD C DRINGS P VONPAWEL J RICCI S DORNOFF W VANWALREE N HUININK WT CHEMAISSANI A STAHEL P BERGMAN B WAGENIUS G SEDERHOLM C MATTSON K LIIPPO K KELLOKUMPULEHTINEN P
Citation: C. Manegold et al., A RANDOMIZED STUDY OF GEMCITABINE MONOTHERAPY VERSUS ETOPOSIDE CISPLATIN IN THE TREATMENT OF LOCALLY ADVANCED OR METASTATIC NONSMALL CELL LUNG-CANCER/, Seminars in oncology, 24(3), 1997, pp. 813-817
LOBAPLATIN (D-19466) IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER - A TRIAL OF THE ASSOCIATION-FOR-MEDICAL-ONCOLOGY (AIO) PHASE-II STUDY-GROUP
Authors: MANEGOLD C DRINGS P GATZEMEIER U VONPAWEL J FIEBIG HH QUEISSER W EDLER L
Citation: C. Manegold et al., LOBAPLATIN (D-19466) IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER - A TRIAL OF THE ASSOCIATION-FOR-MEDICAL-ONCOLOGY (AIO) PHASE-II STUDY-GROUP, Onkologie, 19(3), 1996, pp. 248-251
PHASE-II STUDY OF PACLITAXEL AND CISPLATIN IN PATIENTS WITH NONSMALL CELL LUNG-CANCER
Authors: VONPAWEL J WAGNER H NIEDERLE N HEIDER A KOSCHEL G HECKER D HANSKE M
Citation: J. Vonpawel et al., PHASE-II STUDY OF PACLITAXEL AND CISPLATIN IN PATIENTS WITH NONSMALL CELL LUNG-CANCER, Seminars in oncology, 23(6), 1996, pp. 47-50
SINGLE-AGENT PACLITAXEL AS A 3-HOUR INFUSION
Authors: GATZEMEIER U NEUHAUSS R SCHLUTER I VONPAWEL J WAGNER H DIERGARTEN K
Citation: U. Gatzemeier et al., SINGLE-AGENT PACLITAXEL AS A 3-HOUR INFUSION, Seminars in oncology, 23(6), 1996, pp. 94-97
PACLITAXEL AND CISPLATIN IN PATIENTS WITH NONSMALL CELL LUNG-CANCER -RESULTS OF A PHASE-II TRIAL
Authors: VONPAWEL J WAGNER H NIEDERLE N HEIDER A KOSCHEL G GROMOTKA E HANSKE M
Citation: J. Vonpawel et al., PACLITAXEL AND CISPLATIN IN PATIENTS WITH NONSMALL CELL LUNG-CANCER -RESULTS OF A PHASE-II TRIAL, Seminars in oncology, 23(5), 1996, pp. 7-9
DOSE-INTENSIFICATION OF V-ICE CHEMOTHERAPY WITH GM-CSF IN SMALL-CELL LUNG-CANCER (SCLC) - A PROSPECTIVE RANDOMIZED STUDY OF 301 PATIENTS
Authors: STEWARD WP VONPAWEL J GATZEMEIER U THATCHER N FRISCH J
Citation: Wp. Steward et al., DOSE-INTENSIFICATION OF V-ICE CHEMOTHERAPY WITH GM-CSF IN SMALL-CELL LUNG-CANCER (SCLC) - A PROSPECTIVE RANDOMIZED STUDY OF 301 PATIENTS, European journal of cancer, 31A, 1995, pp. 80-80
RECOMBINANT GRANULOCYTE-COLONY-STIMULATING FACTOR IN THE TREATMENT OFSMALL-CELL LUNG-CANCER - A LONG-TERM FOLLOW-UP
Authors: TRILLETLENOIR V GREEN JA MANEGOLD C VONPAWEL J GATZEMEIER U LEBEAU B DEPIERRE A JOHNSON P DECOSTER G MATCHAM J EWEN C
Citation: V. Trilletlenoir et al., RECOMBINANT GRANULOCYTE-COLONY-STIMULATING FACTOR IN THE TREATMENT OFSMALL-CELL LUNG-CANCER - A LONG-TERM FOLLOW-UP, European journal of cancer, 31A(12), 1995, pp. 2115-2116
CHEMOTHERAPY OF ADVANCED INOPERABLE NON-SMALL-CELL LUNG-CANCER WITH PACLITAXEL - A PHASE-II TRIAL
Authors: GATZEMEIER U HECKMAYER M NEUHAUSS R SCHLUTER I VONPAWEL J WAGNER H DREPS A
Citation: U. Gatzemeier et al., CHEMOTHERAPY OF ADVANCED INOPERABLE NON-SMALL-CELL LUNG-CANCER WITH PACLITAXEL - A PHASE-II TRIAL, Seminars in oncology, 22(6), 1995, pp. 24-28
VALUE OF SERUM AND EFFUSION FLUID CEA LEVELS FOR DISTINGUISHING BETWEEN DIFFUSE MALIGNANT MESOTHELIOMA AND CARCINOMATOUS PLEURAL METASTASES
Authors: MEZGER J CALAVREZOS A DRINGS P GATZEMEIER U KAUKEL E KONIETZKO N KOSCHEL G LAMERZ R VONPAWEL J ROMER W
Citation: J. Mezger et al., VALUE OF SERUM AND EFFUSION FLUID CEA LEVELS FOR DISTINGUISHING BETWEEN DIFFUSE MALIGNANT MESOTHELIOMA AND CARCINOMATOUS PLEURAL METASTASES, Lung, 172(3), 1994, pp. 183-184
IN-111 PENTETREOTIDE IN THE DIAGNOSTIC WORK-UP OF PATIENTS WITH BRONCHOGENIC-CARCINOMA
Authors: KIRSCH CM VONPAWEL J GRAU I TATSCH K
Citation: Cm. Kirsch et al., IN-111 PENTETREOTIDE IN THE DIAGNOSTIC WORK-UP OF PATIENTS WITH BRONCHOGENIC-CARCINOMA, European journal of nuclear medicine, 21(12), 1994, pp. 1318-1325
Risultati: 1-22 |